Although the role of IL-6 in senescence-induced anti-tumour effects was reported in non-HCC [162], the role of IL6 in senescence-mediated anti-tumour effects in different types of liver cancers is still under investigation and seems to be dependent on the tumour type (E.G., personal communication). The gene discussed is IL6; the disease is hepatocellular carcinoma.